Holmium laser enucleation versus bipolar resection in the management of large-volume benign prostatic hyperplasia: A randomized controlled trial

Bibliographic Information
Authors: Habib E.; Abdallah M.F.; ElSheemy M.S.; Badawy M.H.; Nour H.H.; Kamal A.M.; AbdelMohsen M.; Roshdy M.A.; Meshref A.
Journal: International Journal of Urology
Publisher: John Wiley and Sons Inc
Publication Date: 17 November 2021
Volume / Issue: Volume 29 / Issue 2
Pages: 128–135
ISSN: 9198172
DOI: 10.1111/iju.14737
Scopus: View on Scopus
PubMed: 34788900
Document Type: Article
Authors and Affiliations
Habib E., Urology Department, Kasr Al-Ainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt; Abdallah M.F., Urology Department, Theodor Bilharz Research Institute, Giza, Egypt; ElSheemy M.S., Urology Department, Kasr Al-Ainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt; Badawy M.H., Urology Department, Theodor Bilharz Research Institute, Giza, Egypt; Nour H.H., Urology Department, Theodor Bilharz Research Institute, Giza, Egypt; Kamal A.M., Urology Department, Theodor Bilharz Research Institute, Giza, Egypt; AbdelMohsen M., Urology Department, Kasr Al-Ainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt; Roshdy M.A., Urology Department, Theodor Bilharz Research Institute, Giza, Egypt; Meshref A., Urology Department, Kasr Al-Ainy Hospitals, Faculty of Medicine, Cairo University, Cairo, Egypt
Abstract
Objectives: To compare the mid-term safety and efficacy of holmium laser enucleation of the prostate versus bipolar transurethral resection of the prostate in the management of large-volume benign prostatic hyperplasia. Methods: From December 2016 to March 2018, patients with benign prostatic hyperplasia (≥80 cc) were randomized (block randomization, computer-generated random list) to holmium laser enucleation of the prostate (57 patients) or bipolar transurethral resection of the prostate (55 patients). Patients were excluded if they had an International Prostate Symptom Score <13, a maximum urinary flow rate >15 mL/s or presence of prostate cancer, bladder stone, urethral stricture, neurogenic bladder, or previous prostate surgery. The primary outcome was hemoglobin loss. The analysis was intention-to-treat. Postoperative findings (36 months) were compared to baseline characteristics. Univariate and logistic regression analyses were performed for risk factors predicting hemoglobin loss or operative time in all patients. Results: There was no significant difference in baseline characteristics between the two groups. Holmium laser enucleation of the prostate was associated with significantly better operative time (P = 0.019), operative efficiency (P < 0.001), hemoglobin loss (P < 0.001), catheterization duration (P < 0.001) and hospital stay (P < 0.001) compared to bipolar transurethral resection of prostate. Both procedures were safe, with no significant difference in total complications (P = 0.128). Blood transfusion (P = 0.026) and capsular perforation (P = 0.239) were reported only in the bipolar transurethral resection of the prostate group. There was no significant difference in rates of urinary tract infections (P = 0.714), urethral strictures (P = 0.359), or transient stress incontinence (P = 0.717). At the last follow-up (3 years), holmium laser enucleation of the prostate was associated with significantly better International Prostate Symptom Scores, prostate-specific antigen levels and maximum urinary flow rates compared to bipolar transurethral resection of the prostate (P < 0.05). In logistic regression analyses, prostate size and bipolar transurethral resection of the prostate were associated with significantly greater hemoglobin loss, whereas prostate size, capsular perforation, and bipolar transurethral resection of the prostate were associated with significantly longer operative time. Conclusion: Holmium laser enucleation of the prostate and bipolar transurethral resection of the prostate are effective and safe for the management of moderate-to-severe lower urinary tract symptoms attributable to large-volume benign prostatic hyperplasia (≥80 cc). However, if both techniques are available, holmium laser enucleation of the prostate is preferred due its better efficacy and safety profile. © 2021 The Japanese Urological Association
Keywords
Humans; Laser Therapy; Lasers, Solid-State; Male; Prostatic Hyperplasia; Quality of Life; Transurethral Resection of Prostate; Treatment Outcome; hemoglobin; prostate specific antigen; aged; antigen blood level; Article; blood transfusion; catheterization; clinical outcome; controlled study; enucleation; hospitalization; human; intention to treat analysis; major clinical study; operation duration; patient safety; perforation; postoperative complication; prostate hypertrophy; prostate size; randomized controlled trial; risk factor; stress incontinence; therapy effect; transurethral resection; treatment duration; urethra stenosis; urinary tract infection; urine flow rate; urine incontinence; urine retention; adverse device effect; adverse event; low level laser therapy; solid state laser
Citation Information
Scopus Citations: 23
For comprehensive information about the Theodor Bilharz Research Institute (TBRI), its institutional activities, scientific and research achievements, clinical and hospital services, and the diverse expertise offered through its 22 specialized research and clinical departments, as well as opportunities for professional training, specialized workshops, and scientific conferences, readers are invited to visit the Institute’s official website.
The website provides regularly updated information on the Institute’s latest news, research activities, scientific initiatives, clinical services, institutional programs, and academic and professional opportunities.
English Website: https://www.tbri.sci.eg/en/
Arabic Website: https://www.tbri.sci.eg/ar/
Prepared and Uploaded by:
Abdalla F. Abdalla
Electronic Portal Unit
